{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:13:36Z","timestamp":1790878416476,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1245\/s10434-024-15633-x","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T15:02:49Z","timestamp":1719846169000},"page":"6764-6773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Participation in a High-Risk Program Is Associated with a Diagnosis of Earlier-Stage Disease Among Women at Increased Risk for Breast Cancer Development"],"prefix":"10.1245","volume":"31","author":[{"given":"Melissa","family":"Pilewskie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idil","family":"Eroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varadan","family":"Sevilimedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiana","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Mangino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,29]]},"reference":[{"key":"15633_CR1","volume-title":"Cancer Facts and Figures 2022","author":"American Cancer Society","year":"2022","unstructured":"American Cancer Society. Cancer Facts and Figures 2022. Atlanta: American Cancer Society; 2022."},{"key":"15633_CR2","unstructured":"U.S. Cancer Statistics Working Group. Cancer Statistics Data Visualizations Tool, based on 2020 submission data (1999\u20132018). U.S. Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute. www.cdc.gov\/cancer\/dataviz. Accessed 17 June 2024."},{"key":"15633_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity, and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62:676\u201389.","journal-title":"Am J Hum Genet."},{"key":"15633_CR4","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PDP, Antoniou AC, et al. Gene-panel sequencing and the prediction of breast cancer risk. N Engl J Med. 2015;372:2243\u201357.","journal-title":"N Engl J Med."},{"key":"15633_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bpobgyn.2019.11.006","volume":"65","author":"MA Thorat","year":"2020","unstructured":"Thorat MA, Balasubramanian R. Breast cancer prevention in high-risk women. Best Pract Res Clin Obstet Gynaecol. 2020;65:18\u201331.","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"15633_CR6","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","volume":"33","author":"TA King","year":"2015","unstructured":"King TA, Pilewskie M, Muhsen S, et al. Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol. 2015;33:3945\u201352.","journal-title":"J Clin Oncol."},{"key":"15633_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jamaoncol.2016.3022","volume":"3","author":"TS Menes","year":"2017","unstructured":"Menes TS, Kerlikowske K, Lange J, Jaffer S, Rosenberg R, Miglioretti DL. Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy. JAMA Oncol. 2017;3:36\u201341.","journal-title":"JAMA Oncol."},{"key":"15633_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jama.290.4.465","volume":"290","author":"LB Travis","year":"2003","unstructured":"Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290:465\u201375.","journal-title":"JAMA."},{"key":"15633_CR9","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1200\/JCO.1996.14.5.1442","volume":"14","author":"R Sankila","year":"1996","unstructured":"Sankila R, Garwicz S, Olsen JH, et al. Risk of subsequent malignant neoplasms among 1641 Hodgkin\u2019s disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. J Clin Oncol. 1996;14:1442\u20136.","journal-title":"J Clin Oncol."},{"key":"15633_CR10","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1245\/s10434-012-2257-y","volume":"19","author":"B Drohan","year":"2012","unstructured":"Drohan B, Roche CA, Cusack JC, Hughes KS. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol. 2012;19:1732\u20137.","journal-title":"Ann Surg Oncol."},{"key":"15633_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10549-018-05123-6","volume":"175","author":"M Pilewskie","year":"2019","unstructured":"Pilewskie M, Zabor EC, Gilbert E, et al. Differences between screen-detected and interval breast cancers among BRCA mutation carriers. Breast Cancer Res Treat. 2019;175:141\u20138.","journal-title":"Breast Cancer Res Treat."},{"key":"15633_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1067\/j.cpradiol.2020.04.008","volume":"50","author":"N Amornsiripanitch","year":"2021","unstructured":"Amornsiripanitch N, Ameri SM, Goldberg RJ. Primary care providers underutilize breast screening MRI for high-risk women. Curr Prob Diagnostic Radiol. 2021;50:489\u201394.","journal-title":"Curr Prob Diagnostic Radiol."},{"key":"15633_CR13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1089\/jwh.2017.6623","volume":"27","author":"R Miles","year":"2018","unstructured":"Miles R, Wan F, Onega TL, et al. Underutilization of supplemental magnetic resonance imaging screening among patients at high breast cancer risk. J Women\u2019s Health. 2018;27:748\u201354.","journal-title":"J Women's Health."},{"key":"15633_CR14","unstructured":"Hornik K, the R Core Team. The R FAQ. 2024. https:\/\/CRAN.R-project.org\/doc\/manuals\/R-FAQ.html."},{"key":"15633_CR15","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402\u201316.","journal-title":"JAMA."},{"key":"15633_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75\u201389.","journal-title":"CA Cancer J Clin."},{"key":"15633_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317\u201325.","journal-title":"JAMA."},{"key":"15633_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.18865\/ed.32.2.81","volume":"32","author":"JML Young","year":"2022","unstructured":"Young JML, Postula KJV, Duquette D, Gutierrez-Kapheim M, Pan V, Katapodi MC. Accuracy of perceived breast cancer risk in black and white women with an elevated risk. Ethn Dis. 2022;32:81\u201390.","journal-title":"Ethn Dis."},{"key":"15633_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1188\/09.ONF.306-314","volume":"36","author":"MC Katapodi","year":"2009","unstructured":"Katapodi MC, Dodd MJ, Lee KA, Facione NC. Underestimation of breast cancer risk: influence on screening behavior. Oncol Nurs Forum. 2009;36:306\u201314.","journal-title":"Oncol Nurs Forum."},{"key":"15633_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJMsr1407164","volume":"372","author":"LC Hartmann","year":"2015","unstructured":"Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast: risk assessment and management options. N Engl J Med. 2015;372:78\u201389.","journal-title":"N Engl J Med."},{"key":"15633_CR21","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.2214\/AJR.20.23480","volume":"216","author":"MP Hogan","year":"2021","unstructured":"Hogan MP, Amir T, Sevilimedu V, Sung J, Morris EA, Jochelson MS. Contrast-enhanced digital mammography screening for intermediate-risk women with a history of lobular neoplasia. AJR Am J Roentgenol. 2021;216:1486\u201391.","journal-title":"AJR Am J Roentgenol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15633-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15633-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15633-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T14:25:01Z","timestamp":1726755901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15633-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["15633"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15633-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,29]]},"assertion":[{"value":"2 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}